Drugdiscovery >> Clinical Trials >> News
8117
Views
Glioblastoma multiforme vaccine successful in Phase 2 - drugdiscovery.com
Glioblastoma multiforme vaccine successful in Phase 2 - drugdiscovery.com


Agenus’ Prophage Series G-100 (HSPPC-96), used in combination with the current standard of care in patients with newly diagnosed glioblastoma multiforme, showed significant improvement in progression free survival, compared to current standard of care alone.
Read More >>


Tags: glioblastoma multiiforme, GBM, vaccine, clinical trial, Ageon, HSPPC-96,progression free survival - September 19, 2013
Related Articles
3624
Views
Dose-dense temozolomide shows no benefit for glioblastoma patients Dose-dense temozolomide shows no benefit for glioblastoma patients
The results of a randomized trial showed that radiation therapy and dose-dense temozolomide (Temodar) did not have improved efficacy compared to conventional treatment with radiation therapy and temoz Read More >>

Tags: temozolomide, Temodar, dose-dense, glioblastoma multiforme, clinical trial

4992
Views
A combination of conventional and gene therapy for treatment of deadly brain cancer A combination of conventional and gene therapy for treatment of deadly brain cancer
A phase I human clinical trial is expected to start early in 2014. Newly diagnosed glioblastoma multiforme patients, along with standard of care that includes chemo-radiotherapy, will also be treated Read More >>

Tags: glioblastoma multiforme, clinical trial, gene therapy, stem cells, oncolytic adenovirus, neural stem cells,HB1.F3 NSC

4646
Views
The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate  The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate
The intramuscular bivalent (GI/GII) norovirus vaccine candidate in healthy adults who were challenged with the most commonly occurring norovirus that causes gastroenteritis showed promise in a Phase 1 Read More >>

Tags: Takeda, vaccine, norovirus, gastroenteritis, clinical trial

7068
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

5075
Views
GSK’s  malaria vaccine candidate shows promise in Phase 3 trial GSK’s malaria vaccine candidate shows promise in Phase 3 trial
According to the results of a large-scale Phase 3 trial, the vaccine candidate RTS,S, showed efficient at protecting young children and infants from clinical malaria up to 18 months after vaccination. Read More >>

Tags: GSK, malaria vaccine, malaria, RTS,S, clinical trial

6316
Views
Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial
The experimental vaccine consists of a disk-shaped, biodegradable sponge which contains growth factors and components of each patient's tumors aiming to recruit and reprogram a patient’s own immune Read More >>

Tags: melanoma, cancer, clinical trial, skin, implant, implantable, vaccine

6137
Views
Boehringer Ingelheim’s  COPD drug successful in  Phase 3 studies Boehringer Ingelheim’s COPD drug successful in Phase 3 studies
The results show that olodaterol Respimat, in addition to usual care, provides statistically significant improvements in lung function in patients with COPD, compared to usual care alone. Read More >>

Tags: olodaterol Respimat, COPD, drug, new treatment, Boehringer Ingelheim, Boehringer, clinical trial

7473
Views
Novo Nordisk’s type 2 diabetes therapy successful in Phase 3 trial Novo Nordisk’s type 2 diabetes therapy successful in Phase 3 trial
The data from DUALT 1 trial show that an investigational therapy IDegLira [Tresiba (insulin degludec)/Victoza (liraglutide injection)] achieved statistically significant greater reduction in blood sug Read More >>

Tags: Novo Nordisk, type 2 diabetes, DUALT 1 trial, IDegLira, Tresiba, insulin degludec, Victoza, liraglutide, combination

8318
Views
Medivir’s bone drug successful in Phase 1 clinical trial Medivir’s bone drug successful in Phase 1 clinical trial
The investigational cathepsin K inhibitor MIV-711, used as the treatment of osteoarthritis and other bone related disorders, has shown to be safe and tolerable at doses where it potently decreased car Read More >>

Tags: Medivir, cathepsin K inhibitor, MIV-711, osteoarthritis, bone, drug, invstigational, clinical trial

6317
Views
Trajenta successful  in Phase III trial in elderly Type 2 diabetes patients Trajenta successful in Phase III trial in elderly Type 2 diabetes patients
Trajenta (linagliptin), marketed by Eli Lilly and Boehringer Ingelheim, showed safe and effective in Phase III trial, significantly reducing the blood glucose levels in elderly people with Type 2 diab Read More >>

Tags: Trajenta, type 2 diabetes, elderly, blood glucose control

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013